(Q24243125)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253535%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

0 references

1 reference

title

Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253535%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

0 references

0 references

metabolic dysfunction–associated steatotic liver disease

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253535%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

F Lirussi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253535%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

S Orando

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253535%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

R Orlando

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253535%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

F Angelico

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253535%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

24 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253535%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253535%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253535%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

CD004996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253535%20AND%20SRC:MED&resulttype=core&format=json

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

N-acetylcysteine in the treatment of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Vitamin E treatment in pediatric obesity-related liver disease: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Probucol in the treatment of nonalcoholic steatohepatitis: an open-labeled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Treatment of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Unsuspected cirrhosis discovered during elective obesity operations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Etiopathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Methods for combining randomized clinical trials: strengths and limitations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Update on nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Nonalcoholic fatty liver disease: an agenda for clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004996.PUB3

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

21 January 2018

1 reference

12 December 2020

Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study

1 reference

12 December 2020

Efficacy and safety of oral betaine glucuronate in non-alcoholic steatohepatitis. A double-blind, randomized, parallel-group, placebo-controlled prospective clinical study

1 reference

12 December 2020

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

1 reference

12 December 2020

Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Diisopropylamine dichloroacetate in the treatment of nonalcoholic fatty liver disease: a multicenter random double-blind controlled trial

1 reference

12 December 2020

Effects of a new pharmacological complex (silybin + vitamin-E + phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study

1 reference

12 December 2020

Natural history of nonalcoholic steatohepatitis

1 reference

12 December 2020

The epidemiology of nonalcoholic fatty liver disease in adults

1 reference

12 December 2020

Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis

1 reference

12 December 2020

Nonalcoholic steatohepatitis: An expanded clinical entity

1 reference

12 December 2020

[Glutathione in the treatment of chronic fatty liver diseases]

1 reference

12 December 2020

Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study

1 reference

12 December 2020

10.1002/14651858.CD004996.PUB3

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

2846787

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253535%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

2846787

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253535%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

2 references

Consolidated OpenCitations Corpus – April 2017

2846787